Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-Based Detection of Proximal Caries Across Radiographic Modalities: A Systematic Review and Meta-Analysis.

Dento maxillo facial radiology·2026
Same author

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

CA: a cancer journal for clinicians·2026
Same author

LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signaling.

Oncogene·2026
Same author

Tumor-infiltrating clonal hematopoiesis is associated with adverse clinical outcomes in diffuse large B-cell lymphoma.

Blood cancer discovery·2026
Same author

Tumour-Derived Extracellular Vesicles Induce Diffuse Large B-Cell Lymphoma Progression Through Macrophage-Mediated MDSC Accumulation.

Journal of extracellular vesicles·2026
Same author

N6-methyladenosine reader IGF2BP2 in T-cell lymphoma.

Blood·2026

Related Experiment Video

Updated: Aug 3, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.3K

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.

Rong Shen1, Di Fu1, Lei Dong2

  • 1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics; National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Signal Transduction and Targeted Therapy
|April 9, 2023
PubMed
Summary
This summary is machine-generated.

A new LymphPlex algorithm classifies diffuse large B-cell lymphoma (DLBCL) into seven genetic subtypes. This classification reveals distinct biological signatures and guides targeted therapy for improved patient outcomes.

More Related Videos

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.8K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K

Related Experiment Videos

Last Updated: Aug 3, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.3K
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.8K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K

Area of Science:

  • Genomics and Molecular Biology
  • Hematology and Oncology
  • Precision Medicine

Background:

  • Diffuse large B-cell lymphoma (DLBCL) exhibits significant molecular heterogeneity.
  • Understanding this heterogeneity is crucial for identifying therapeutic implications.
  • Existing classification systems may not fully capture the molecular landscape of DLBCL.

Purpose of the Study:

  • To develop a simplified genetic classification algorithm for DLBCL.
  • To identify distinct genetic subtypes within DLBCL.
  • To evaluate the clinical relevance and biological signatures of these subtypes for guiding targeted therapy.

Main Methods:

  • Whole exome/genome sequencing, RNA-sequencing, and fluorescence in situ hybridization were employed.
  • A 38-gene algorithm (LymphPlex) was established based on mutations in 35 genes and rearrangements in BCL2, BCL6, and MYC.
  • Validation was performed on 1001 DLBCL patients to assess clinical relevance and biological characteristics.

Main Results:

  • Seven distinct genetic subtypes were identified: TP53Mut, MCD-like, BN2-like, N1-like, EZB-like, and ST2-like.
  • Each subtype exhibited unique prognostic implications, biological signatures (e.g., signaling pathway activation, immune microenvironment), and associations with DLBCL origins (ABC/GCB).
  • Genetic subtype-guided targeted agents showed encouraging clinical responses when combined with immunochemotherapy.

Conclusions:

  • The LymphPlex algorithm provides a feasible and effective method for classifying DLBCL into distinct genetic subtypes.
  • This classification elucidates the molecular heterogeneity and clinical relevance of different DLBCL subtypes.
  • LymphPlex represents a significant advancement towards mechanism-based targeted therapy in DLBCL.